Key Insights

Highlights

Success Rate

85% trial completion

Published Results

17 trials with published results (14%)

Research Maturity

73 completed trials (60% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.7%

13 terminated out of 122 trials

Success Rate

84.9%

-1.6% vs benchmark

Late-Stage Pipeline

18%

22 trials in Phase 3/4

Results Transparency

23%

17 of 73 completed with results

Key Signals

17 with results85% success13 terminated

Data Visualizations

Phase Distribution

83Total
Not Applicable (31)
Early P 1 (1)
P 1 (19)
P 2 (10)
P 3 (7)
P 4 (15)

Trial Status

Completed73
Unknown22
Terminated13
Withdrawn6
Recruiting3
Active Not Recruiting3

Trial Success Rate

84.9%

Benchmark: 86.5%

Based on 73 completed trials

Clinical Trials (122)

Showing 20 of 20 trials
NCT00001971Recruiting

Evaluation of Patients With Liver Disease

NCT02520609CompletedPrimary

Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease

NCT05899231Not ApplicableRecruiting

Online Prehabilitation for Patients Awaiting Liver Transplantation

NCT07378514Not Yet Recruiting

Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices

NCT02070315CompletedPrimary

Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM

NCT00804583Active Not Recruiting

Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease

NCT01847612Phase 3CompletedPrimary

Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy

NCT06482112Phase 2Completed

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

NCT07032311Not ApplicableNot Yet Recruiting

Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk

NCT00550849Phase 1TerminatedPrimary

Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction

NCT06980571Not ApplicableCompletedPrimary

Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections

NCT02382822Active Not Recruiting

Copenhagen Comorbidity in HIV Infection Study

NCT03814005Phase 1Completed

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

NCT04014413Not ApplicableRecruiting

Safety and Efficacy of Fecal Microbiota Transplantation

NCT02873663Not ApplicableActive Not Recruiting

Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease

NCT04116242CompletedPrimary

MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease

NCT01437969CompletedPrimary

Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.

NCT01789008Not ApplicableCompleted

Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.

NCT04883177Completed

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

NCT04185454Not ApplicableCompleted

Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese

Scroll to load more

Research Network

Activity Timeline